CoChat

Attacking cancer's Achilles heel: antagonism of anti‐apoptotic BCL‐2 family members

Open access
Opferman, Joseph T. · 2016 · The FEBS Journal
Cited by 113

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Malignant cells routinely violate cellular checkpoints that should initiate cell death in normal cells by triggering pro‐apoptotic members of the BCL‐2 family of proteins. To escape such death inducing signals, cancer cells often select for upregulation of anti‐apoptotic BCL‐2 family members including BCL‐2, BCL‐X L, BFL‐1, BCL‐W and MCL‐1. These family members prevent death by sequestering pro‐apoptotic molecules. To counter this resistance mechanism, small molecule inhibitors of anti‐apoptotic BCL‐2 family members have been under development. These molecules have shown promise in pre‐clinical and clinical testing to overcome apoptotic resistance, prompting cancer cells to undergo apoptosis. Alternatively, other strategies have taken advantage of the normal regulatory machinery controlling anti‐apoptotic molecules and have used inhibitors of signaling pathways to down‐modulate the expression of anti‐apoptotic molecules, thus tilting the balance in cancer cells to cell death. This review explores recent developments and strategies aimed at antagonizing anti‐apoptotic BCL‐2 family member action to promote the induction of cell death in cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/febs.13472

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 113

Metadata

Authors
Opferman, J. T.
Venue
The FEBS Journal
Publisher
Wiley
Published
2015-09-15
Volume
283
Issue
14
Pages
2661-2675
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W2142098498
Cited by
113
References
11
FWCI
6.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.